Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Peer Review reports

Original Submission
1 Nov 2011	Submitted	Original manuscript
15 Nov 2011	Author responded	Author comments - Birgit Luber
Resubmission - Version 2
15 Nov 2011	Submitted	Manuscript version 2
Resubmission - Version 3
	Submitted	Manuscript version 3
Resubmission - Version 4
	Submitted	Manuscript version 4
6 Dec 2011	Author responded	Author comments - Birgit Luber
Resubmission - Version 5
6 Dec 2011	Submitted	Manuscript version 5
Publishing
7 Dec 2011	Editorially accepted
7 Dec 2011	Article published	10.1186/1471-2407-11-509

Back to article page